The CRISPR-Cas system in clinical strains of Acinetobacter baumannii: an in-silico analysis

Arturo Martínez-Trejo1, Juan Manuel Ruiz-Ruiz2, Luis Uriel Gonzalez-Avila1

  • 1Laboratorio de Investigación Clínica y Ambiental, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico.

PubMed

Insights

The CRISPR-Cas system in Acinetobacter baumannii may help it resist phages. This study analyzed genomes, finding the CRISPR-Cas system potentially linked to resistance genes but not virulence.

Area of Science:

  • Microbiology
  • Genomics
  • Bioinformatics

Background:

  • Acinetobacter baumannii exhibits high antimicrobial resistance, often linked to genetic material acquisition.
  • The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas system is involved in managing foreign genetic elements and influences bacterial physiology.

Purpose of the Study:

  • To investigate the presence, distribution, and characteristics of the CRISPR-Cas system in clinical strains of Acinetobacter baumannii.
  • To explore the potential association of the CRISPR-Cas system with antimicrobial resistance and virulence genes.

Main Methods:

  • In-silico analysis of 91 fully assembled Acinetobacter baumannii genomes from the NCBI database.
  • Bioinformatic tools were employed to identify and characterize CRISPR-Cas system subtypes, architecture, and phylogeny.
  • Analysis of spacer sequences and correlation with resistance and virulence genes.

Main Results:

  • The I-F1 subtype of the CRISPR-Cas system was identified across the analyzed genomes, with variations in its architecture and phylogeny.
  • A potential association was observed between the CRISPR-Cas system and antimicrobial resistance genes.
  • No significant association was found between the CRISPR-Cas system and virulence determinants.
  • Spacer sequence analysis suggested a role in protection against phage infections.

Conclusions:

  • The CRISPR-Cas system, specifically the I-F1 subtype, is present and variable in clinical Acinetobacter baumannii strains.
  • The system may play a protective role against phage infections and is potentially linked to antimicrobial resistance.
  • Further research is warranted to elucidate the precise mechanisms and implications of the CRISPR-Cas system in Acinetobacter baumannii pathogenesis and resistance.